In this expert perspective from Hawaiian Eye 2026, Francis W. Price Jr., MD, of Price Vision Group, discusses the latest in neurotrophic keratitis.Price said pharmaceuticals are under study for ...
Oxervate is a prescription eye drop approved for the treatment of neurotrophic keratitis. It is suitable for adults and children ages two years and older. Oxervate is a brand-name prescription drug ...
Viatris Inc. (NASDAQ:VTRS) is one of the top cheap stocks under $20 to buy now. On December 18, Viatris Inc. (NASDAQ:VTRS) announced four recent regulatory milestones spread across all stages of the ...
"We are proud of these recent regulatory achievements, which culminate a year of significant R&D advancement in 2025," said Viatris Chief R&D Officer Philippe Martin. "These important milestones not ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
Neurotrophic keratitis, also known as neurotrophic keratopathy (NK), is a degenerative disease of the cornea caused by damage to the ophthalmic branch of the trigeminal nerve. A healthy cornea and a ...
Shares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a phase I/II study evaluating its eye drop KB801 for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results